A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

Clinical trial NCT00503451 · COMPLETED

Trial details

NCT number: NCT00503451
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Neoplasms

Start date: 2007-09-01
Primary completion: 2010-04-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.